The global移植市场size is expected to reach USD 19.52 billion by 2028 according to a new study by Polaris Market Research. The report“Transplantation Market Share, Size, Trends, Industry Analysis Report, By Product Type (Tissue Products, Immunosuppressive Drugs, and Preservation Solutions); By Application (Organ and Tissue Transplant), By End Use (Hospitals, Transplant Centers, and Others), By Regions; Segment Forecast, 2021 –2028”gives a detailed insight into current market dynamics and provides analysis on future market growth.
在2020年，移植的组织市场分部占最大的份额，并预计将保留其主导地位。发达经济体患者患者全球血腥和大型移植产品的燃烧和事故案件案例升高。根据欧洲道路安全天文台的估计，西班牙大约有102,362例事故案件，促进了细分市场在移植行业的增长前景。
预计器官移植细胞将以评估期的最快速度增长。重复使用免疫抑制剂和上升器官移植手术是负责这种高增长率的突出市场因素。此外，移植技术的进步随后新产品推出推动肾脏，肺，心脏，组织和肝脏的透明程序。
有问题吗？在通过单击下面的链接，请在购买此报告之前请求示例或进行查询：//m.nkkjrh.com/industry-analysis/transplantation-market/request-for-sample
从这个方向，在2020年11月，卢普在美国领土中引入了一种免疫抑制药物“Tacrolimus”的通用版本，用于在同种异体心脏，肝脏和肾移植中的器官排斥。最近几年来，德国，法国，美国的德国录制了大量的移植程序。和英国，该数字预计未来几年将会上升。此外，在这些国家的熟练医疗基础设施和熟练外科医生的可用性的存在已经赞成移植的市场增yabo娱乐vip长。
The immunosuppressive drugs market segment is anticipated to grow at a lucrative growth rate over the study. This market growth is attributed to its high usage post organ transplantation and the rising prevalence of chronic diseases. Thus, the rising market demand for such drugs is anticipated to grow at the fastest rate.
The preservation market segment is projected to witness a significant growth rate over the assessment period. Strong government funding towards stem cell research and the rising cases of organ failures are the factors expected to favor the market segment’s growth prospects in transplantation industry.
米arket participants in transplantation industry include Stryker Corp., Zimmer Biomet, Biolife Solutions, Medtronic, Teva Pharmaceutical, AbbVie Inc., Novartis International, 21st Century Medicine, and Veloxis Pharmaceuticals.
Polaris Market Research has segmented the transplantation market report on the basis of product type, application, end-use, and region:
Transplantation, Product Type Outlook (Revenue – USD Million, 2016 – 2028)
- Tissue Products
- Immunosuppressive Drugs
- Preservation Solutions
移植，申请前景（收入 - 百万，2016 - 2028）
- Organ Transplant
- 组织移植
移植，最终用途前景（收入 - 百万，2016 - 2028）
- 医院
- 移植中心
- 其他
Transplantation, by Regional Outlook (Revenue – USD Million, 2016 – 2028)
- 北美
- U.S.
- Canada
- Europe
- France
- Germany
- 英国
- Italy
- Spain
- 荷兰
- 奥地利
- 亚太地区
- 中国
- India
- 日本
- 米alaysia
- 韩国
- 印度尼西亚
- 中美洲和南美洲
- 米exico
- Brazil
- Argentina
- 中东和非洲
- 阿联酋
- 沙特阿拉伯
- Israel
- 南非